X4 Pharmaceuticals, Inc Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • X4 Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$36.7M, a 1492% decline year-over-year.
  • X4 Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$16.8M, a 84.9% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$101M, a 7.78% decline from 2022.
  • X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$93.9M, a 5.83% decline from 2021.
  • X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$88.7M, a 42.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$101M -$7.3M -7.78% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$93.9M -$5.17M -5.83% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$88.7M -$26.6M -42.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$62.1M -$9.32M -17.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
2019 -$52.8M -$19.5M -58.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$33.3M -$11.3M -51.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-19
2017 -$22M +$981K +4.27% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$23M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.